Martinón-Torres, F;
García-Sastre, A;
Pollard, AJ;
Martín, C;
Osterhaus, A;
Ladhani, SN;
Ramilo, O;
Gómez Rial, J;
Salas, A;
Bosch, FX;
et al.
Martinón-Torres, F; García-Sastre, A; Pollard, AJ; Martín, C; Osterhaus, A; Ladhani, SN; Ramilo, O; Gómez Rial, J; Salas, A; Bosch, FX; Martinón-Torres, M; Mina, MJ; Cherry, J
(2021)
TIPICO XI: report of the first series and podcast on infectious diseases and vaccines (aTIPICO).
Hum Vaccin Immunother, 17 (11).
pp. 4299-4327.
ISSN 2164-554X
https://doi.org/10.1080/21645515.2021.1953351
SGUL Authors: Ladhani, Shamez Nizarali
Abstract
TIPiCO is an annual expert meeting and workshop on infectious diseases and vaccination. The edition of 2020 changed its name and format to aTIPiCO, the first series and podcasts on infectious diseases and vaccines. A total of 13 prestigious experts from different countries participated in this edition launched on the 26 November 2020. The state of the art of coronavirus disease-2019 (COVID-19) and the responsible pathogen, the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), and the options to tackle the pandemic situation were discussed in light of the knowledge in November 2020. Despite COVID-19, the status of other infectious diseases, including influenza infections, respiratory syncytial virus disease, human papillomavirus infection, measles, pertussis, tuberculosis, meningococcal disease, and pneumococcal disease, were also addressed. The essential lessons that can be learned from these diseases and their vaccines to use in the COVID-19 pandemic were also commented with the experts.
Item Type: |
Article
|
Additional Information: |
© 2021 The Author(s). Published with license by Taylor & Francis Group, LLC.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
Keywords: |
COVID-19 pandemic, Infectious disease, control of transmission, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), vaccine-immunity response, vaccine-preventable disease, COVID-19, Communicable Diseases, Humans, Influenza Vaccines, Pandemics, SARS-CoV-2, Humans, Communicable Diseases, Influenza Vaccines, Pandemics, COVID-19, SARS-CoV-2, Infectious disease, vaccine-preventable disease, COVID-19 pandemic, control of transmission, vaccine-immunity response, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), 1107 Immunology, 1108 Medical Microbiology, 1115 Pharmacology and Pharmaceutical Sciences, Virology |
SGUL Research Institute / Research Centre: |
Academic Structure > Infection and Immunity Research Institute (INII) |
Journal or Publication Title: |
Hum Vaccin Immunother |
ISSN: |
2164-554X |
Language: |
eng |
Dates: |
Date | Event |
---|
2 November 2021 | Published | 11 November 2021 | Published Online | 2 July 2021 | Accepted |
|
Publisher License: |
Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0 |
Projects: |
Project ID | Funder | Funder ID |
---|
UNSPECIFIED | Instituto de Salud Carlos III | http://dx.doi.org/10.13039/501100004587 | PI070069 | Fondo de Investigación Sanitaria | UNSPECIFIED | PI1601569 | Fondo de Investigación Sanitaria | UNSPECIFIED | UNSPECIFIED | fondos FEDER | UNSPECIFIED | Proyectos GaIN Rescata-Covid_IN845D 2020/23 | GAIN | UNSPECIFIED | PI1000540 | Fondo de Investigación Sanitaria | UNSPECIFIED | PI1901090 | Fondo de Investigación Sanitaria | UNSPECIFIED |
|
PubMed ID: |
34762551 |
Web of Science ID: |
WOS:000717355800001 |
|
Go to PubMed abstract |
URI: |
https://openaccess.sgul.ac.uk/id/eprint/114696 |
Publisher's version: |
https://doi.org/10.1080/21645515.2021.1953351 |
Statistics
Item downloaded times since 24 Aug 2022.
Actions (login required)
|
Edit Item |